“…The LPS-primed cells were replaced with RPMI 1640 media (350 μL per well) containing an inflammasome trigger with maltol (ESFOOD, #186785643, Gunpo-si, Gyeonggi-do, Korea). The inflammasome triggers are as follows: ATP (5 mM, InvivoGen, San Diego, CA, USA) for 1 h, nigericin (NG, 40 μM, Tocris Bioscience, Bristol, UK) for 1 h, monosodium urate crystals (MSU, 400 μg/mL, Sigma-Aldrich Co., Burlington, MA, USA) for 3 h, flagellin (500 ng/mL; Invivogen, San Diego, CA, USA) with Lipofectamine 2000 (10 μL/mL, Invitrogen, Carlsbad, CA, USA) for 3 h, dsDNA (1 μg/mL) with jetPRIME TM (2 μL/mL, Polyplus-transfection Inc., Illkirch, France) for 1 h, LPS (2 μg/mL, Sigma-Aldrich Co., Burlington, MA, USA) with FuGENE ® HD (2.5 μL/mL, Roche, Penzberg, Germany) for 6 h, and rotenone (160 μM, Santa Cruz Biotechnology, Dallas, TX, USA) for 6 h [ 24 , 25 ].…”